GEVO Earnings

GEVO reported its FY2025Q4 earnings on 2026-03-05, showcasing a revenue of against an estimate of 43.52M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.03 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following GEVO's FY2025Q4 earnings announcement on 2026-03-05, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, GEVO's stock price tends to shift by an average of 5.46% in the 10 days leading up to earnings and 6.89% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate GEVO's annual revenue to reach 44.33M, while the EPS is projected at -0.03. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between GEVO's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GEVO's stock price typically moves by 5.46% in the 10 days before its earnings and 6.89% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -0.03 and revenue of 44.33M.

The earnings call highlights strong financial metrics, including substantial ethanol and carbon credit production, and optimistic guidance on future projects like the ATJ-30 and Verity software. The Q&A section reinforced confidence with detailed plans for EBITDA growth and DOE financing. While there were some vague responses, the overall sentiment is positive due to strategic partnerships, market opportunities, and technological advancements, suggesting a likely positive stock price movement.